Disulfiram-Copper Potentiates Anticancer Efficacy of Standard Chemotherapy Drugs in Bladder Cancer Animal Model through ROS-Autophagy-Ferroptosis Signalling Cascade.

Saved in:
Bibliographic Details
Title: Disulfiram-Copper Potentiates Anticancer Efficacy of Standard Chemotherapy Drugs in Bladder Cancer Animal Model through ROS-Autophagy-Ferroptosis Signalling Cascade.
Authors: Sharma N; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Dey S; Department of Urology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Singh S; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Kumar S; Department of Histopathology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Konar M; Department of Biochemistry, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Naithani P; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Panwar R; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Rastogi P; Department of Hematology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Kakkar AK; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Mavuduru RS; Department of Urology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Pattanaik S; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Source: Current cancer drug targets [Curr Cancer Drug Targets] 2025; Vol. 25 (9), pp. 1145-1157.
Publication Type: Journal Article
Journal Info: Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101094211 Publication Model: Print Cited Medium: Internet ISSN: 1873-5576 (Electronic) Linking ISSN: 15680096 NLM ISO Abbreviation: Curr Cancer Drug Targets Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5576
DOI:10.2174/0115680096325879240815105227